Style | Citing Format |
---|---|
MLA | Bozorgmehr R, et al.. "Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial." Clinical Respiratory Journal, vol. 14, no. 4, 2020, pp. 370-381. |
APA | Bozorgmehr R, Edalatifard M, Safavi E, Rahimi B, Ghorbani F, Abtahi H, Amini S, Pourdowlat G (2020). Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial. Clinical Respiratory Journal, 14(4), 370-381. |
Chicago | Bozorgmehr R, Edalatifard M, Safavi E, Rahimi B, Ghorbani F, Abtahi H, Amini S, Pourdowlat G. "Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial." Clinical Respiratory Journal 14, no. 4 (2020): 370-381. |
Harvard | Bozorgmehr R et al. (2020) 'Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial', Clinical Respiratory Journal, 14(4), pp. 370-381. |
Vancouver | Bozorgmehr R, Edalatifard M, Safavi E, Rahimi B, Ghorbani F, Abtahi H, et al.. Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial. Clinical Respiratory Journal. 2020;14(4):370-381. |
BibTex | @article{ author = {Bozorgmehr R and Edalatifard M and Safavi E and Rahimi B and Ghorbani F and Abtahi H and Amini S and Pourdowlat G}, title = {Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial}, journal = {Clinical Respiratory Journal}, volume = {14}, number = {4}, pages = {370-381}, year = {2020} } |
RIS | TY - JOUR AU - Bozorgmehr R AU - Edalatifard M AU - Safavi E AU - Rahimi B AU - Ghorbani F AU - Abtahi H AU - Amini S AU - Pourdowlat G TI - Therapeutic Effects of Nebulized Verapamil on Chronic Obstructive Pulmonary Disease: A Randomized and Double-Blind Clinical Trial JO - Clinical Respiratory Journal VL - 14 IS - 4 SP - 370 EP - 381 PY - 2020 ER - |